Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Platinum in Neoadjuvant Lung Adenocarcinoma
NCT02980991Phase 2Completed
- Sponsor
- Fudan University
- Start
- Dec 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed and cisplatin in lung adenocarcinoma, sponsored by Fudan University. Primary endpoint: Radiological Response Rate. Started Dec 2015; status: completed.
02
Drugs
pemetrexedcisplatin
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT02980991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02980991.